Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Apple is appealing the ITC's Apple Watch injunction, but it has been able to continue selling the Apple Watch by disabling ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's smartwatches infringe ...

Apple has sought an injunction against health tech maker Masimo’s own smart watches, but it also netted the bare minimum for ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

It is in the middle for Revenue Growth. All You Need to Know About Masimo Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare ...

Masimo Corp. is suing founder Joe Kiani—who lost a takeover fight last month against Politan Capital Management LP—saying he ...

Masimo (MASI) delivered earnings and revenue surprises of 16.67% and 0.40%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

In this article, we are going to take a look at where Masimo Corporation (NASDAQ:MASI) stands against other most promising medical stocks. The healthcare sector depends on medical technology ...